Sacha , T. (2014) “Deep molecular response (MR4.5) as a target of therapy with tyrosine kinase inhibitors. MR4.5 – goal of CML treatment”, OncoReview, 4(1(13), pp. 26-32. Available at: https://journalsmededu.pl/index.php/OncoReview/article/view/356 (Accessed: 23November2024).